Millipore Launches Antibody Learning Center
News Apr 16, 2008
Millipore Corporation has announced the launch of the new Antibody Learning Center, a free web tool for navigating Millipore’s broad antibody portfolio and planning efficient workflows for immunodetection in specific focus areas of protein research.
Now that Upstate and Chemicon are part of Millipore, Millipore’s antibody offerings span the entire range of biological research, from neuroscience, cell signaling and nuclear function, to cell structure and adhesion, and apoptosis. The Antibody Learning Center conveniently organizes the entire antibody collection into specific focus areas. Researchers can find the relevant antibodies to answer a particular question while they are also alerted to important, related proteins, extending the scope of their research.
As Millipore extends its antibody offerings, we also validate all antibodies with appropriate techniques and documented protocols such as Western blotting or more rigorous applications, such as immunoprecipitation or immunohistochemistry.
The Antibody Learning Center is fully integrated with Millipore’s online product catalog, providing customers with valuable technical and validation information. Customers who have trusted Millipore’s filtration and water purification products for decades can now depend on Millipore antibodies and invaluable customer service. For many, this service will begin at the Antibody Learning Center, at www.millipore.com/antibodies.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE